J. Lobo

Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease

J. Simon, G. Pasinetti, S. Percival, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism*

J. Simon, P. Davies, V. Vingtdeux, 2010, The Journal of Biological Chemistry.

Brain-Targeted Proanthocyanidin Metabolites for Alzheimer's Disease Treatment

Sara M. Levens, A. Kania, S. Perlmutter, 2012, The Journal of Neuroscience.

Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease.

J. Simon, C. Weaver, G. Pasinetti, 2009, Journal of Alzheimer's disease : JAD.

Bioavailability of gallic acid and catechins from neuroprotective grape seed extract is improved by repeated dosing in rats

J. Simon, G. Pasinetti, L. Ho, 2009 .

Bioavailability of grape‐derived polyphenolics and implications in Alzheimer's disease prevention and therapy

J. Simon, G. Pasinetti, S. Percival, 2010 .

Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease

G. Pasinetti, S. Percival, L. Ho, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Brain-Targeted Proanthocyanidin Metabolites for Alzheimer's Disease Treatment

R. Dixon, C. Pavlides, D. Teplow, 2012, The Journal of Neuroscience.

Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease.

C. Weaver, G. Pasinetti, L. Ho, 2009, Journal of Alzheimer's disease : JAD.